ClinicalTrials.gg
CompletedNCT03106337Updated May 16, 2017Results posted

Diagnostic Accuracy of Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular Lesions of the Thyroid

An interventional study of Shear-Wave Elastography in Thyroid Nodule and Follicular Neoplasm, sponsored by Massachusetts General Hospital. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-05-16.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 4 years 3 months after the study started (first participant enrolled Jan 2010, registered Apr 2014).
Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

As many as 70-85% subjects diagnosed with a follicular lesion on biopsy and undergoing surgery will have benign lesions verified by histopathology after surgery.

Currently there is no method of pre-operatively diagnosing benign follicular lesions, as a result these subjects will have had surgery for diagnosis of a benign lesion.

The aim of this study is to see whether shear-wave elastography, a new ultrasound technology can help pre-operatively diagnose benign follicular lesions. If successful, a lot of patients will not need surgery for the diagnosis of a benign lesion.

The main goal of this study will be to evaluate the diagnostic accuracy of a new ultrasound technology, shear-wave elastography (SWE), for the diagnosis of malignancy in follicular lesions. Participants who have been diagnosed with a follicular lesion on thyroid biopsy and are scheduled for thyroid surgery will be eligible to participate. All participants will undergo a detailed ultrasound examination prior to their surgery. The results of the ultrasound will be compared with histopathology after surgery to test the diagnostic accuracy of SWE.

02

Conditions studied

  • Thyroid Nodule
  • Follicular Neoplasm

Keywords

  • Thyroid
  • Follicular Neoplasms
  • Bethesda System
  • Elastography
  • Doppler ultrasound
  • Thyroidectomy
03

In context

Thyroid Nodule

203 studies on the registry are indexed under Thyroid Nodule; 57 are open to participants now.

This study's enrollment of 35 is below the median of 80 across 120 interventional studies indexed under Thyroid Nodule.

Browse Thyroid Nodule studies →

Lead sponsor

Massachusetts General Hospital is the lead sponsor of 2,582 studies on the registry; 451 are open to participants now.

Of its 221 completed or terminated interventional studies of FDA-regulated products, 168 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with a Follicular Neoplasm on fine needle aspiration biopsy
  • Patients >18 years of age

Exclusion criteria

Exclusion Criteria

  • None
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Shear-Wave Elastography

    Shear-Wave Elastography was performed on patients scheduled for partial/total thyroidectomy. Results were compared with pathology from surgical excision.

    Device: Shear-Wave Elastography

Interventions

  • DeviceShear-Wave Elastography

    Shear-Wave Elastography was performed on patients scheduled for partial/total thyroidectomy. Results were compared with pathology from surgical excision.

    Also known as: Supersonic Aixplorer

06

What researchers measure

Primary outcomes

  1. Shear-Wave Elastography (SWE) Values in kiloPascals (kPa)

    Elastography provides a quantitative score of thyroid nodule stiffness that is expected to correlate with the biological nature of the nodule. Mean SWE values, in three planes: traverse plane, sagittal plane and transverse plane with nodule in the center, of all benign lesions were compared with mean SWE values of all malignant lesions on histopathology obtained post surgery.

    Time frame: Baseline (Day 0)

07

Results

Posted May 16, 2017

Participant flow

Participant flow — Overall Study
MilestoneShear-Wave Elastography
Started35
Completed35
Not completed0

Outcome measures

PrimaryShear-Wave Elastography (SWE) Values in kiloPascals (kPa)

Elastography provides a quantitative score of thyroid nodule stiffness that is expected to correlate with the biological nature of the nodule. Mean SWE values, in three planes: traverse plane, sagittal plane and transverse plane with nodule in the center, of all benign lesions were compared with mean SWE values of all malignant lesions on histopathology obtained post surgery.

Time frame:
Baseline (Day 0)
Reported as:
Mean · kPa
Shear-Wave Elastography (SWE) Values in kiloPascals (kPa)
kPaShear-Wave Elastography, Benign LesionsShear-Wave Elastography, Malignant Lesions
Transverse Plane17.50 ± 7.6531.03 ± 13.54
Sagittal Plane23.64 ± 14.8632.14 ± 11.98
Transverse Plane with Nodule in the Center17.89 ± 9.133.80 ± 12.50

Adverse events

Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Shear-Wave Elastography—0/35 (0%)0/35 (0%)

Baseline characteristics

All enrolled participants.

Age, Continuous
Age, Continuous(years)Shear-Wave Elastography
Mean55 ± 16.1
Sex: Female, Male
Sex: Female, Male(Participants)Shear-Wave Elastography
Female23
Male12
Region of Enrollment
Region of Enrollment(participants)Shear-Wave Elastography
United States35
08

Study locations

1 site
  • Massachusetts General Hospital
    Boston, Massachusetts 02114, United States
09

References and documents

Publications

  • Samir AE, Dhyani M, Anvari A, Prescott J, Halpern EF, Faquin WC, Stephen A. Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular-patterned Lesions of the Thyroid: Diagnostic Accuracy and Optimal Measurement Plane. Radiology. 2015 Nov;277(2):565-73. doi: 10.1148/radiol.2015141627. Epub 2015 May 7. PubMed 25955578 ↗

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03106337
Responsible party
Antonia Stephen, MD (Assistant Professor of Surgery, Massachusetts General Hospital) — Principal investigator
First posted
Apr 10, 2017
Start date
Jan 2010
Primary completion
Apr 2012
Completion
Apr 2012
Results posted
May 16, 2017
Last update
May 16, 2017

Study contacts

Antonia E. Stephen, MD
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion